Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial

BACKGROUND: In patients with prostate cancer (PCa) with histopathologically proven pelvic lymph node (LN) metastasis (pN1) after extended pelvic lymph node dissection (ePLND), multimodality treatment consisting of treatment of the primary tumor and whole pelvic radiotherapy (WPRT) combined with andr...

Descripción completa

Detalles Bibliográficos
Autores principales: Draulans, Cédric, Joniau, Steven, Fonteyne, Valérie, Delrue, Louke, Decaestecker, Karel, Everaerts, Wouter, Dirix, Piet, Van den Bergh, Laura, Crijns, Wouter, Vandendriessche, Hans, Van Wynsberge, Lodewijk, Ost, Piet, Lumen, Nicolaas, Buelens, Pieterjan, Haustermans, Karin, Berghen, Charlien, De Meerleer, Gert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315267/
https://www.ncbi.nlm.nih.gov/pubmed/30545809
http://dx.doi.org/10.2196/11256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315267/
https://www.ncbi.nlm.nih.gov/pubmed/30545809
http://dx.doi.org/10.2196/11256

Ejemplares similares